NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Selumetinib Shrinks Pediatric Tumors, Results of an Early-Phase Clinical Trial

Brigitte C. Widemann, M.D., acting chief of the National Cancer Institute’s (NCI) Pediatric Oncology Branch, discusses the results of her phase 1 trial, which evaluated the toxicity and safety of selumetinib in patients with the common genetic disorder neurofibromatosis type 1 (NF1) and inoperable plexiform neurofibromas.